Internal Medicine, Gastroenterology · Omaha, NE
NPI
1447225784
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
8901 Indian Hills Dr, Suite 200
Omaha, NE, 68114
Phone (402) 397-7057
Groups this clinician bills Medicare through
Medicare paid, 2024
$694K
35,901 services
Medicare patients, 2024
762
Average age 74
Drug cost, 2024
$693K
1,428 prescriptions
Company payments, 2025
$2,705
From 16 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tyron A Alli was code J3380 (injection, vedolizumab, intravenous, 1 mg), 24,300 times for 58 patients. In total Tyron A Alli billed 35,901 services in 72 codes, and Medicare paid $694K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3380 Injection, vedolizumab, intravenous, 1 mg | Office | 24,300 | 58 | $17.14 | $416K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,720 | 39 | $24.33 | $90K |
| 99232 Hospital E&M - Subsequent | Facility | 172 | 96 | $56.98 | $9,800 |
| 43239 Upper GI Endoscopy | Facility | 170 | 166 | $71.08 | $12K |
| 45385 Colonoscopy - Lesion Removal | Facility | 165 | 165 | $186.72 | $31K |
| 99214 Office E&M - Established | Office | 113 | 103 | $81.57 | $9,218 |
| 36415 Venipuncture Blood Collection | Office | 88 | 67 | $8.56 | $753 |
| 96365 Intravenous Infusion, Hydration | Office | 85 | 61 | $43.66 | $3,711 |
| 96413 Chemotherapy Administration | Office | 79 | 56 | $85.13 | $6,726 |
| 99222 Hospital E&M - Initial | Facility | 64 | 64 | $93.84 | $6,006 |
| 99213 Office E&M - Established | Office | 62 | 59 | $59.69 | $3,701 |
| G0105 Colorectal cancer screening; colonoscopy on individual at high risk | Facility | 49 | 49 | $158.97 | $7,790 |
| 45380 Lower GI Endoscopy - Other | Facility | 45 | 44 | $104.96 | $4,723 |
| 99204 Office E&M - New | Office | 41 | 41 | $98.28 | $4,030 |
| 43450 Digestive/Gastrointestinal | Facility | 36 | 36 | $27.17 | $978 |
By year: 2022 $707K for 31,880 services; 2023 $642K for 29,997 services; 2024 $694K for 35,901 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 88 | 67 | $8.56 | $753 |
Medicare prescription drug claims, 2024
In 2024, the drug Tyron A Alli prescribed most often to Medicare patients was Peg 3350-Electrolyte (Sodium Chloride/Nahco3/Kcl/Peg), with 265 prescriptions and refills. In total Tyron A Alli wrote 1,428 Medicare prescriptions that cost $693K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Peg 3350-Electrolyte Sodium Chloride/Nahco3/Kcl/Peg | 265 | 282 | 260 | $5,499 |
| Pantoprazole Sodium Generic | 209 | 418 | 54 | $1,530 |
| Dicyclomine Hcl Generic | 165 | 201 | 41 | $2,666 |
| Omeprazole Generic | 94 | 205 | 25 | $1,352 |
| Mercaptopurine Generic | 70 | 96 | 12 | $4,656 |
| Colestipol Hcl Generic | 64 | 74 | 15 | $3,337 |
| Metoclopramide Hcl Generic | 53 | 78 | 17 | $364 |
| Ursodiol Generic | 43 | 63 | Under 11 | $5,660 |
| Nortriptyline Hcl Generic | 42 | 56 | Under 11 | $211 |
| Linzess Linaclotide | 35 | 38 | Under 11 | $20K |
| Gavilyte-N Sodium Chloride/Nahco3/Kcl/Peg | 33 | 33 | 33 | $430 |
| Amitriptyline Hcl Generic | 25 | 43 | Under 11 | $312 |
| Mesalamine Er Mesalamine | 23 | 35 | Under 11 | $1,664 |
| Xifaxan Rifaximin | 21 | 21 | Under 11 | $79K |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 20 | 20 | 20 | $1,269 |
Brand drugs: 296 claims; generic drugs: 1,132 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tyron A Alli $2,705 ($2,705 in general payments such as food, travel and fees) from 16 companies. The largest payer was Genzyme Corporation with $353.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 6 | $353 |
| Phathom Pharmaceuticals, Inc. PHAT | 11 | $334 |
| Abbvie Inc. ABBV | 16 | $292 |
| Janssen Biotech, Inc. JNJ | 3 | $279 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $266 |
| Madrigal Pharmaceuticals MDGL | 16 | $238 |
| Gilead Sciences, Inc. GILD | 7 | $233 |
| Ardelyx, Inc. ARDX | 7 | $183 |
| Lilly USA, LLC LLY | 3 | $136 |
| Intercept Pharmaceuticals, Inc. | 2 | $133 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.